宜昌天仁药业有限责任公司
Yichang Tianren Pharmaceutical Co. Ltd.
Country: CN CDE+DMF+CEP HIGH
🇨🇳 CDE
25
25 products shown
🇺🇸 DMF
1
1 products shown
🇪🇺 CEP
1
1 products shown
Total
27
registrations
🇨🇳 CDE 注册 (25)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Ambrisentan 安立生坦 | 177036-94-1 | Class A | Y20180001630 |
| Brivaracetam 布瓦西坦 | 357336-20-0 | Class I | Y20240001533 |
| Dimethyl Fumarate 富马酸二甲酯 | 624-49-7 | Class A | Y20210000588 |
| Dyclonine 盐酸达克罗宁 | 586-60-7 | Class I | Y20170002319 |
| Enoxacin 葡萄糖酸依诺沙星 | 74011-58-8 | Class A | Y20190004410 |
| Finerenone HS236 | 1050477-31-0 | Class I | Y20250000755 |
| Flumazenil 氟马西尼 | 78755-81-4 | Class A | Y20220000153 |
| Gadobutrol 钆布醇 | 770691-21-9 | Class A | Y20230001328 |
| Glycine 甘氨酸 | 56-40-6 | Class A | Y20200000734 |
| Istradefylline 伊曲茶碱 | 155270-99-8 | Class I | Y20240001237 |
| Levobupivacaine 盐酸左布比卡因 | 27262-48-2 | Class A | Y20170001136 |
| Mirtazapine 米氮平 | 85650-52-8 | Class A | Y20170000719 |
| Palonosetron 盐酸帕洛诺司琼 | 135729-61-2 | Class A | Y20230000742 |
| Pefloxacin Mesylate 甲磺酸培氟沙星 | 70458-92-3 | Class A | Y20190004411 |
| Propanol 苯丙醇 | 71-23-8 | Class A | Y20190004416 |
| Ropivacaine 盐酸罗哌卡因 | 84057-95-4 | Class A | Y20200000905 |
| Ropivacaine Hydrochloride 罗哌卡因 | 84057-95-4 | Class I | Y20250001426 |
| Solifenacin 琥珀酸索利那新 | 242478-37-1 | Class A | Y20180000716 |
| Tadalafil 他达拉非 | 171596-29-5 | Class A | Y20180001750 |
| Telmisartan 替米沙坦 | 144701-48-4 | Class A | Y20190005299 |
| Umifenovir 盐酸阿比多尔 | 131707-25-0 | Class A | Y20170001345 |
| Valaciclovir 盐酸伐昔洛韦 | 124832-26-4 | Class A | Y20210000655 |
| Valaciclovir 盐酸伐昔洛韦 | 124832-26-4 | Class A | Y20190009334 |
| Valganciclovir 盐酸缬更昔洛韦 | 175865-60-8 | Class A | Y20240000645 |
| Vonoprazan 富马酸伏诺拉生 | 881681-00-1 | Class A | Y20220000268 |
🇺🇸 DMF 注册 (1)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Valacyclovir Hydrochloride 伐昔洛韦 | 124832-27-5 | - | 2011-02-25 |
🇪🇺 CEP 注册 (1)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Valaciclovir Hydrochloride Hydrate 伐昔洛韦 | 1218948-84-5 | CEP 2022-137 - Rev 00 | - |
Source: cde_raw | Updated: 2026-04-09 07:23:01